Engineering polysialylation of scFvs and its effects on function
Antibody engineering for drug therapy has become a major industry in recent years, with much work focussed on the development of recombinant antibody fragments in therapeutic and diagnostic applications. An important consideration when engineering antibodies, especially rapidly clearing fragments is...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2013
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.576027 |